United States· US:0220-1634_0a0c732a-320f-a40c-e063-6394a90aa6a2
Curare
A tubocurarine product containing tubocurarine chloride, registered in United States by Boiron. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tubocurarine is registered in 2 of 19 countries.
Countries holding a registration under ATC M03AA02 (tubocurarine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Tubocurarine · ATC M03AA02
2 / 19 countries
- Finlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TUBOCURARINE CHLORIDE
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- M03AA02
- ATC class
- Tubocurarine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11022016344130 [hp_C] in 1 TUBE (0220-1634-41)
- ndc110220-1634-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
50 interactions on record for tubocurarine.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tubocurarine · interactions on record
50 records
- 12 severe
- 34 moderate
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M03AA02
Tubocurarine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf22d35b-e0e4-47a4-a8bb-1c8dfe328900 GET /v1/drugs/cf22d35b-e0e4-47a4-a8bb-1c8dfe328900?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "TUBOCURARINE CHLORIDE",
"productndc": "0220-1634",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/30[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about tubocurarine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.